Abstract
Background: Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4] triazin-7(4H)-one, TZV) is an antiviral drug synthesized. TZV is being investigated for potential application against the Coronavirus 2019-nCoV.
Aims and Objectives: In order to find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug Triazavirin (C5H4N6O3S) which may work as inhibitor for the Mpro of 2019-nCoV.
Methods: In the present work, first time the molecular structure of title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in gas phase.
Results: The molecular HOMO-LUMO, excitation energies and oscillator strengths of investigated compound have also been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular docking studies.
Conclusion: Therefore, TZV can be used for potential application against the Coronavirus 2019-nCoV.
Keywords: Triazavirin, coronavirus, DFT, electronic properties, molecular docking, HOMO-LUMO.
Current Molecular Medicine
Title:Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
Volume: 21 Issue: 8
Author(s): Siyamak Shahab and Masoome Sheikhi*
Affiliation:
- Independent Researcher, Gonbad-e-Kavoos,Iran
Keywords: Triazavirin, coronavirus, DFT, electronic properties, molecular docking, HOMO-LUMO.
Abstract:
Background: Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4] triazin-7(4H)-one, TZV) is an antiviral drug synthesized. TZV is being investigated for potential application against the Coronavirus 2019-nCoV.
Aims and Objectives: In order to find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug Triazavirin (C5H4N6O3S) which may work as inhibitor for the Mpro of 2019-nCoV.
Methods: In the present work, first time the molecular structure of title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in gas phase.
Results: The molecular HOMO-LUMO, excitation energies and oscillator strengths of investigated compound have also been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular docking studies.
Conclusion: Therefore, TZV can be used for potential application against the Coronavirus 2019-nCoV.
Export Options
About this article
Cite this article as:
Shahab Siyamak and Sheikhi Masoome *, Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study, Current Molecular Medicine 2021; 21 (8) . https://dx.doi.org/10.2174/1566524020666200521075848
DOI https://dx.doi.org/10.2174/1566524020666200521075848 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological
Exploration
Coronaviruses The Two fACEs of the Tissue Renin-Angiotensin Systems: Implication in Cardiovascular Diseases
Current Pharmaceutical Design Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents
Current Pharmaceutical Design Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19)
Combinatorial Chemistry & High Throughput Screening Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?
Infectious Disorders - Drug Targets A Pharmacophore Model Specific to Active Site of CYP1A2 with a Novel Molecular Modeling Explorer and CoMFA
Medicinal Chemistry A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2
Combinatorial Chemistry & High Throughput Screening Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic
Reviews on Recent Clinical Trials Immunity Modulators, Repurposed Drugs and Candidate Vaccines for COVID-19: A Review
Coronaviruses Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Predicting Protein-Ligand Binding Sites Based on an Improved Geometric Algorithm
Protein & Peptide Letters Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment
Current HIV Research Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease
Current Pharmaceutical Design Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry Impact of Coronavirus Outbreak on Climate and Air Quality
Current Signal Transduction Therapy Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance
Current Drug Targets Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19
Current Medicinal Chemistry Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19
Mini-Reviews in Medicinal Chemistry Novel Coronavirus Disease and the Current Scenario of the Global Health Emergency
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Toward the Virtual Screening of Potential Drugs in the Homology Modeled NAD+ Dependent DNA Ligase from Mycobacterium tuberculosis
Protein & Peptide Letters